• A novel aryl-guanidinium derivative, VP79s, targets the signal transducer and activator of transcription 3 signaling pathway, downregulates myeloid cell leukaemia-1 and exhibits preclinical activity against multiple myeloma

    Simple item page

    Files

    Original bundle

    Now showing 1 - 1 of 1
    Thumbnail Image
    Name:
    Amet et al 2022.pdf
    Size:
    2.74 MB
    Format:
    Adobe Portable Document Format
    Description:
    Download

    License bundle

    Now showing 1 - 1 of 1
    Thumbnail Image
    Name:
    license.txt
    Size:
    3.42 KB
    Format:
    Item-specific license agreed upon to submission
    Description:
    Download

    Collections

    Haematology (Scholarly Publications)
    RSS Feeds